Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Huge potential for profit in THE NEW YEAR

<< Previous

Bullboard Posts

Next >>

Post by knowsbeston Dec 23, 2020 11:49am

247 Views

Post# 32169579

Huge potential for profit in THE NEW YEAR

This stock is best position for major gains in the first few months in the NEW YEAR .Lots of research was done over the last few months by our team of dedicated stock researchers >LOTS and LOTS of DD .All indicators point in one direction UP>>UP >>UP

Merry Christmas and a very Happy and Prosperous NEW YEAR. to all MYCO holders

<< Previous

Bullboard Posts

Next >>

How a truck transportation and logistics company leverages acquisitions and technology